46708-683 : Rivaroxaban 2.5 mg Oral Tablet, Film Coated


NDC46708-683
Labeler: Alembic Pharmaceuticals Limited
Product Type: Human Prescription Drug
Drug Name:  Rivaroxaban
Dosage Form: Oral Tablet, Film Coated
Application #: ANDA210301
Rev. Date: 


NDC Package Codes:

  • 46708-683-10: 100 BLISTER PACK IN 1 CARTON (46708‑683‑10) / 10 TABLET, FILM COATED IN 1 BLISTER PACK
  • 46708-683-45: 180 TABLET, FILM COATED IN 1 BOTTLE (46708‑683‑45)
  • 46708-683-60: 60 TABLET, FILM COATED IN 1 BOTTLE (46708‑683‑60)
  • 46708-683-91: 1000 TABLET, FILM COATED IN 1 BOTTLE (46708‑683‑91)

Active Ingredients:

  • Rivaroxaban

Dosage Strength:

  • 2.5 mg

Pharmaceutical Classes:

  • Factor Xa Inhibitor [EPC]
  • Factor Xa Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 46708-240 RivaroxabanRivaroxaban Kit by Alembic Pharmaceuticals Limited
  • 46708-346 Rivaroxaban 10 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
  • 46708-347 Rivaroxaban 15 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
  • 46708-348 Rivaroxaban 20 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
  • 31722-496 Rivaroxaban 2.5 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 33342-488 Rivaroxaban 2.5 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
  • 43598-981 Rivaroxaban 2.5 mg Oral Tablet by Dr.reddy's Laboratories, Inc.
  • 59651-849 Rivaroxaban 2.5 mg Oral Tablet, Film Coated by Aurobindo Pharma Limited
  • 60505-6256 Rivaroxaban 2.5 mg Oral Tablet, Film Coated by Apotex Corp.
  • 62332-240 RivaroxabanRivaroxaban Kit by Alembic Pharmaceuticals Inc.
  • 62332-346 Rivaroxaban 10 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Inc.
  • 62332-347 Rivaroxaban 15 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Inc.
  • 62332-348 Rivaroxaban 20 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Inc.
  • 62332-683 Rivaroxaban 2.5 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Inc.
  • 67877-882 Rivaroxaban 155 mg Oral Granule, for Suspension by Ascend Laboratories, LLC
  • 68180-709 Rivaroxaban 2.5 mg Oral Tablet, Film Coated by Lupin Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 46708-683 QR Code

< Prev: 46708-682Next: 46708-691 >

Related Discussions:

Rivaroxaban and pain/loss of strength
Hi all. I was diagnosed with a large DVT and numerous PEs in both lungs in October 2015. I was put on Rivaroxaban and ha... 5 replies
Rivaroxaban Reviews
My dad has just started taking this after a stroke and 3 TIAs. He has 15mg per day. He has taken it for 4 days but has b... 5 replies
Rivaroxaban 20mg
My doctor started me on this med. What are the side effects and benefits? They recently found I had an irregular heart b... 4 replies
Rivaroxaban & Pregnancy!
My wife has just fallen pregnant (4 weeks) and has been on Rivaroxaban as she was diagnosed with PE. This wasn't pla... 1 reply
Rivaroxaban 15mg
My mum had blood clots in her leg under her knee. For past 2 weeks she has been taking 15mg Rivaroxaban and since she ca... 1 reply
Rivaroxaban dosage.
My daughter is just go on to rivaroxaban,why do they start on 15 mgs the go up to 20mgs .Thanks,this is new in the UK. #... 1 reply
Pregnancy and rivaroxaban
I have just found out i am about 5/6 weeks pregnant and i am on rivaroxaban. This will be our 4th child. I have been tak... 1 reply
Side effects of Rivaroxaban
Hi. I've been on rivaroxaban for 18 months, had no side effects except gum bleeding sometimes but recently my legs f... 2 replies
Nausea caused by Rivaroxaban?
Hi. I am a 65 year old female and I have been taking Rivaroxaban 20mg daily for 6 weeks now (because I have atrial fibri... 4 replies
what laxative can i take with rivaroxaban
I'm having problems with constipation but am afraid to take a laxative with rivaroxaban. Please let me know what can... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.